Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 268 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.

NCT00389428

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • H. Lee Moffit Cancer Center & Research Institute at the University of S. Florida Tampa, Florida, United States
  • North Shore University Hospital Manhasset, New York, United States
  • New York Presbyterian Hospital Weill Medical College of Cornell University New York, United States
View Trial Details
Completed

Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies

NCT00595686

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • Pfizer Investigational Site Augusta, Georgia, United States
  • Pfizer Investigational Site Chapel Hill, North Carolina, United States
  • Pfizer Investigational Site Pittsburgh, Pennsylvania, United States
  • Pfizer Investigational Site Nashville, Tennessee, United States
View Trial Details
Completed

Repeat Dose Safety Study for Compound to Treat Hematologic Cancer

NCT00881946

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +33 more
Locations
  • Prince of Wales Hospital Sydney, New South Wales, Australia
  • The Alfred Hospital Melbourne, Victoria, Australia
  • Princess Margaret Hospital Toronto, Ontario, Canada
  • Seoul National University Hospital Seoul, South Korea
View Trial Details

Related conditions